These findings highlight the value of future investigations into how MIF and DDT may contribute to clinical and pathological outcomes in SSc, and the mechanisms through which MIF and DDT may contribute to innate immunity, autoimmunity or fibrosis in this disease. This evidence concerns the gene MIF and Autoimmunity.